Proair 10 mg (Tablet)
Unit Price: ৳ 14.00 (20's pack: ৳ 280.00)
Medicine Details
Category | Details |
---|---|
Generic | Montelukast sodium |
Company | Arges life science limited |
Also available as |
Title
- Proair 10 mg Tablet
Categories
- Indications:
- Prophylaxis and chronic treatment of asthma
- Acute prevention of Exercise-Induced Bronchoconstriction (EIB)
- Relief of symptoms of Allergic Rhinitis: Seasonal & Perennial Allergic Rhinitis
- Pharmacology:
- Selective and orally active leukotriene receptor antagonist
- Inhibits the cysteinyl leukotriene receptor (CysLT1)
- Dosage & Administration:
- Adults and adolescents dosage: Montelukast 10 mg tablet once daily
- Pediatric patients dosage: Montelukast 5 mg, 4 mg tablets, or 4 mg oral granules once daily
- No dosage adjustment needed for hepatic and renal insufficiency
- Similar pharmacokinetic profile in elderly and younger adults
- Interaction:
- No apparent increase in adverse reactions when administered with other therapies
- No clinically important effects on the pharmacokinetics of specific drugs
- Used concomitantly with a wide range of commonly prescribed drugs without evidence of clinical adverse interactions
- Contraindications:
- Hypersensitivity to any component of this product
- Side Effects:
- Common: Diarrhoea, fever, gastrointestinal discomfort, headache, nausea, vomiting, skin reactions, upper respiratory tract infection
- Uncommon: Akathisia, anxiety, arthralgia, asthenia, abnormal behavior, depression, dizziness, drowsiness, dry mouth, haemorrhage, irritability, malaise, muscle complaints, oedema, seizure, abnormal sensation, sleep disorders
- Rare: Angioedema, concentration impaired, disorientation, eosinophilic granulomatosis with polyangiitis, erythema nodosum, hallucination, hepatic disorders, memory loss, palpitations, pulmonary eosinophilia, suicidal tendencies, tremor
- Pregnancy & Lactation:
- Crosses the placenta following oral dosing in rats and rabbits
- Caution should be exercised when given to a nursing mother
- Precautions & Warnings:
- Not indicated for use in the reversal of bronchospasm in acute asthma attacks
- Appropriate rescue medication should be available
- Therapy can be continued during acute exacerbations of asthma
- Should not be abruptly substituted for inhaled or oral corticosteroids
- Should not be used as monotherapy for the treatment and management of exercise induced bronchospasm
- Patients with known aspirin sensitivity should continue avoidance of aspirin or non-steroidal anti-inflammatory agents while taking Proair
- Overdose Effects:
- No adverse experiences in the majority of overdosage reports
- Usual supportive measures should be employed in the event of overdose
- Therapeutic Class:
- Leukotriene receptor antagonists
- Storage Conditions:
- Store in cool & dry place below 30°C
- Protect from light & moisture
- Keep out of reach of children
- Chemical Structure:
- Molecular Formula: C35H36ClNO3S
- Common Questions:
- Used to treat asthma or allergic rhinitis
- Effect can be observed after 1-3 hours of administration
- Effect lasts for an average duration of 24 hours
- May be taken with or without food as prescribed by your doctor
- Use should be avoided in pregnant women unless clearly needed
Other Attributes
- Blocks leukotrienes to keep airways open and enable easy breathing
- No dosage adjustment required for hepatic and renal insufficiency
- Similar pharmacokinetic profile in elderly and younger adults
- No clinically important effects on the pharmacokinetics of specific drugs
- Drug interaction studies show no evidence of clinical adverse interactions
- Appropriate rescue medication should be available for acute asthma attacks
- Therapy can be continued during acute exacerbations of asthma
- Should not be abruptly substituted for inhaled or oral corticosteroids
- Should not be used as monotherapy for the treatment and management of exercise induced bronchospasm
- Caution should be exercised when given to a nursing mother
- Crosses the placenta following oral dosing in rats and rabbits
- Store in cool & dry place below 30°C
- Protect from light & moisture
- Keep out of reach of children
- Molecular Formula: C35H36ClNO3S
- Used to treat asthma or allergic rhinitis
- Effect can be observed after 1-3 hours of administration
- Effect lasts for an average duration of 24 hours
- May be taken with or without food as prescribed by your doctor
- Use should be avoided in pregnant women unless clearly needed
Related Brands
- Aeron FT 4 mg (Dispersible Tablet) - healthcare-pharmaceuticals-ltd
- Aeron FT 5 mg (Dispersible Tablet) - healthcare-pharmaceuticals-ltd
- Aeron 10 mg (Tablet) - healthcare-pharmaceuticals-ltd
- Montinex 4 mg (Chewable Tablet) - beacon-pharmaceuticals-plc
- Montinex 5 mg (Chewable Tablet) - beacon-pharmaceuticals-plc